๊ธ‰์„ฑ ์‹ ์†์ƒ / Acute kidney injury

์ •์˜

48์‹œ๊ฐ„ ์ด๋‚ด Cr 0.3 mg/dL ์ด์ƒ ์ฆ๊ฐ€, 7์ผ ์ด๋‚ด baseline ๋Œ€๋น„ 1.5๋ฐฐ ์ด์ƒ ์ƒ์Šน, ๋˜๋Š” 6์‹œ๊ฐ„ ๋™์•ˆ ์†Œ๋ณ€๋Ÿ‰ 0.5 mL/kg/h ๋ฏธ๋งŒ์œผ๋กœ ๊ฐ์†Œํ•˜๋Š” ์ƒํƒœ.

์ž„์ƒ ํ•ต์‹ฌ

์‘๊ธ‰์‹ค AKI๋Š” prerenal ์›์ธ์ด ํ”ํ•˜๋ฉฐ ํƒˆ์ˆ˜, ์ถœํ˜ˆ, ์‹ฌ๋ถ€์ „, shock, liver disease/HRS, ACEi/ARB ๋“ฑ ํ˜ˆ์••์•ฝ ๊ณผ๋‹ค์™€ ์—ฐ๊ด€๋œ๋‹ค. Prerenal AKI๋Š” FENa <1%๊ฐ€ ๋‹จ์„œ์ด๋ฉฐ ์‹ ์žฅ ์ž์ฒด๋ณด๋‹ค ์‹ ํ˜ˆ๋ฅ˜ ๋ถ€์กฑ์ด ํ•ต์‹ฌ์ด๋‹ค. Intrinsic AKI๋Š” ATN, ์กฐ์˜์ œ/ํ•ญ์ƒ์ œ ๋…์„ฑ, rhabdomyolysis myoglobin, AIN, ์‚ฌ๊ตฌ์ฒด์‹ ์—ผ ๋“ฑ์„ ๊ณ ๋ คํ•œ๋‹ค. Postrenal AKI๋Š” BPH, ์š”๋กœ๊ฒฐ์„, ์ข…์–‘, ์‹ ๊ฒฝ์ธ์„ฑ ๋ฐฉ๊ด‘ ๋“ฑ ํ์‡„๊ฐ€ ์›์ธ์ด๋‹ค.

์ง„๋‹จ

Foley insertion์œผ๋กœ urine output์„ ํ™•์ธํ•œ๋‹ค. Intrinsic ๋˜๋Š” postrenal ์›์ธ์ด ์˜์‹ฌ๋˜๋ฉด ์กฐ์˜์ œ ์‚ฌ์šฉ์ด ์–ด๋ ค์šฐ๋ฏ€๋กœ nonenhance APCT/LDCT APCT๋ฅผ ๊ณ ๋ คํ•œ๋‹ค. Postrenal AKI๋Š” hydronephrosis ๋ฐ ์–‘์ธก ์š”๊ด€ ๋˜๋Š” ๋ฐฉ๊ด‘ ์ดํ•˜ ํ์‡„ ์—ฌ๋ถ€๊ฐ€ ์ค‘์š”ํ•˜๋‹ค.

์น˜๋ฃŒ

์ดˆ๊ธฐ ์ˆ˜์•ก์€ hyperkalemia ์œ„ํ—˜์„ ๊ณ ๋ คํ•ด normal saline์„ ์‚ฌ์šฉํ•œ๋‹ค. Prerenal AKI๋Š” hydration ๋ฐ NSAID/ํ˜ˆ์••์•ฝ ๋“ฑ ์‹ ํ˜ˆ๋ฅ˜ ๋ฐฉํ•ด ์•ฝ๋ฌผ ์ผ์‹œ ์ค‘๋‹จ์ด ํ•ต์‹ฌ์ด๋‹ค. Intrinsic AKI๋Š” ์‹ ๋…์„ฑ ์•ฝ๋ฌผ ์ค‘๋‹จ, AIN/์‚ฌ๊ตฌ์ฒด์‹ ์—ผ์—์„œ๋Š” steroid๋ฅผ ๊ณ ๋ คํ•œ๋‹ค. Postrenal AKI๋Š” Foley, PCN, stent ๋“ฑ์œผ๋กœ ํ์‡„๋ฅผ ํ•ด์†Œํ•œ๋‹ค.

์ถœ์ฒ˜

๐ŸŒฑ ์ถœ์ฒ˜ raw


๋ณธ ๋ฌธ์„œ๋Š” ํ•™์Šตยท์ฐธ๊ณ ์šฉ์ด๋ฉฐ ์‹ค์ œ ์ง„๋ฃŒ ๊ฒฐ์ •์€ ์ž„์ƒ์˜์˜ ํŒ๋‹จ์ž…๋‹ˆ๋‹ค.